While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...
Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
Stocks started the week lower, pulled downward by investors' worries about the health of the AI trade. Under the hood of the ...
Generally, you can count on drugmakers for a steady revenue performance -- since patients need their medicines, revenue holds ...
Here's the list of options activity happening in today's session: These itemized elaborations have been created using the ...
Cigna’s quarterly earnings fell well short of Wall Street’s expectations, as high healthcare costs hurt results in a segment of its insurance business. The company, parent of a pharmacy-benefit ...
For its most recently reported quarter (Q3 of 2024), Hims & Hers generated $401.6 million in revenue. That resulted in a free ...
Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.
ASX healthcare stocks are in the green on Friday, with the S&P/ASX 200 Health Care Index (ASX: XHJ) currently 0.41% higher.
Quest Diagnostics (NYSE: DGX) stock was teasing its all-time high on Thursday, no mean feat for a company that's been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback